EB-1020

· Otsuka Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for EB-1020, covering 2025-08-03 to 2025-12-23. Get the full timeline:

Most recent: Clinical Trial Update: A Long-term Trial of EB-1020 in Pediatric Patients With ADHD [Phase 3]